Company Overview

L'Oréal S.A., through its subsidiaries, manufactures and sells cosmetic products for women and men worldwide. The company operates through four divisions: Consumer Products, L'oréal Luxe, Professional Products, and Active Cosmetics. It offers shampoos, hair care products, shower gels, skin care products, cleansers, hair colors, styling products, deodorants, sun care products, make-up, perfumes, etc. The company provides its products under the L'Oréal Paris, Garnier, Maybelline New York, NYX Professional Makeup, Essie, Niely, Dark and Lovely, Lancôme, Yves Saint Laurent Beauté, Giorgio Armani Beauty, Kiehl's, Urban Decay, Biotherm, Ralph Lauren, IT Cosmetics, L'Oréal Professionnel, Kérastase, Redken, Matrix, Biolage, Pureology, Decléor, Carita, Vichy, La Roche-Posay, SkinCeuticals, Roger&Gallet, CeraVe, Stylenanda, Mixa, Magic Mask, Prada, Helena Rubinstein, Valentino, Mugler, Shu Uemura, Viktor&Rolf, Azzaro, Diesel, Atelier Cologne, Cacharel, and Yue Sai brands. It sells its products through distribution channels, such as hair salons, mass-market retail channels, perfumeries, department stores, pharmacies, drugstores, medispas, branded retail, travel retail, and e-commerce. L'Oréal S.A. was founded in 1909 and is headquartered in Clichy, France.

  • Name

    L'Oréal S.A.

  • CEO

    Mr. Nicolas Hieronimus

  • Website

    www.loreal.com

  • Sector

    Personal Care Products

  • Year Founded

    1909

Profile

  • Market Cap

    €195.74B

  • EV

    €202.2B

  • Shares Out

    534.96M

  • Revenue

    €42.73B

  • Employees

    94,605

Margins

  • Gross

    74.15%

  • EBITDA

    21.99%

  • Operating

    19.85%

  • Pre-Tax

    19.89%

  • Net

    15.17%

  • FCF

    14.05%

Returns (5Yr Avg)

  • ROA

    10.47%

  • ROTA

    20.02%

  • ROE

    17.46%

  • ROCE

    20.43%

  • ROIC

    12.68%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    €441.08

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    €2,728.3M

  • Net Debt

    €6,459.8M

  • Debt/Equity

    0.31

  • EBIT/Interest

    25.57

Growth (CAGR)

  • Rev 3Yr

    12.37%

  • Rev 5Yr

    8.54%

  • Rev 10Yr

    6.88%

  • Dil EPS 3Yr

    18.31%

  • Dil EPS 5Yr

    11.52%

  • Dil EPS 10Yr

    9.44%

  • Rev Fwd 2Yr

    6.59%

  • EBITDA Fwd 2Yr

    6.64%

  • EPS Fwd 2Yr

    7.24%

  • EPS LT Growth Est

    11%

Dividends

  • Yield

  • Payout

    54.49%

  • DPS

    €6.6

  • DPS Growth 3Yr

    18.17%

  • DPS Growth 5Yr

    11.38%

  • DPS Growth 10Yr

    10.19%

  • DPS Growth Fwd 2Yr

    6.85%

ENXTPA:OR